Pharmacom Labs Oxandrolonos is presented in a 100 tablet box with 2 blister packs of 50 tablets each. Each tablet reportedly contains 10 milligrams of oxandrolone according to the label and packaging. Samples of this product were purchased from a North American-based authorized distributor between the dates of June 1, 2015 and June 30, 2015. The samples were forwarded and received by the analytical laboratory SIMEC AG for HPLC-UV testing on July 20, 2015. The quantitative dosage testing report was completed on August 10, 2015. The product was identified with an expiration date of October 15, 2018 and a batch number of MBMN1. There was no verification code printed on the box.
Anavar is the popular brand name associated with the dihydrotestosterone derived anabolic steroid Oxandrolone . The Oxandrolone hormone was first released in the early 1960’s under the trade name Anavar by Searle & co. and was touted as carrying numerous therapeutic qualities. However, in 1989 Searle would discontinue the compound; this was largely due to FDA pressure that had tightened its grip on the anabolic steroid market. An important note; Searle also owned the licensing rights to the majority of Oxandrolone products on the global market, which would lead to this steroid nearly disappearing at this time. In 1995 the Oxandrolone hormone would reappear thanks to Bio-Technology General CORP (BTG), now Savient, under the trade name Oxandrin. BTG would hold a monopoly on the product during this time driving its cost through the roof. Thankfully, a few . based pharmacies such as Watson would begin manufacturing generic Oxandrolone in recent years driving the cost down. However, it remains one of the more expensive anabolic steroids on the market, including when purchased from most underground labs. An important note for future purchase; while Anavar remains the common associated name for the Oxandrolone hormone, the Anavar name itself is not used by any human grade pharmaceutical company that manufactures